Nisa Investment Advisors
SUPN icon

Nisa Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Nisa Investment Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.1K Buy
1,873
+216
+13% +$10.4K ﹤0.01% 1611
2026
Q1 		$85.7K Buy
1,657
+29
+2% +$1.48K ﹤0.01% 1484
2025
Q4 		$80.9K Sell
1,628
-73
-4% -$3.55K ﹤0.01% 1497
2025
Q3 		$81.3K Buy
1,701
+73
+4% +$2.94K ﹤0.01% 1495
2025
Q2 		$51.3K Buy
1,628
+48
+3% +$1.54K ﹤0.01% 1585
2025
Q1 		$51.7K Sell
1,580
-373
-19% -$13.2K ﹤0.01% 1587
2024
Q4 		$70.6K Buy
1,953
+257
+15% +$9.05K ﹤0.01% 1574
2024
Q3 		$52.9K Buy
1,696
+46
+3% +$1.44K ﹤0.01% 1633
2024
Q2 		$44.1K Sell
1,650
-388
-19% -$11.2K ﹤0.01% 1703
2024
Q1 		$69.5K Buy
2,038
+483
+31% +$14.4K ﹤0.01% 1572
2023
Q4 		$45K Sell
1,555
-1,190
-43% -$31.6K ﹤0.01% 1667
2023
Q3 		$75.7K Sell
2,745
-10
-0.4% -$304 ﹤0.01% 1600
2023
Q2 		$82.8K Sell
2,755
-580
-17% -$20.3K ﹤0.01% 1566
2023
Q1 		$121K Sell
3,335
-90
-3% -$3.46K ﹤0.01% 1454
2022
Q4 		$122K Hold
3,425
– – ﹤0.01% 1495
2022
Q3 		$117K Buy
3,425
+35
+1% +$1.14K ﹤0.01% 1434
2022
Q2 		$98K Buy
3,390
+750
+28% +$21.5K ﹤0.01% 1517
2022
Q1 		$85K Sell
2,640
-4,003
-60% -$123K ﹤0.01% 1680
2021
Q4 		$205K Buy
6,643
+2,803
+73% +$85K ﹤0.01% 1263
2021
Q3 		$102 Buy
3,840
+100
+3% +$2.68K ﹤0.01% 1695
2021
Q2 		$115 Buy
3,740
+290
+8% +$8.89K ﹤0.01% 1618
2021
Q1 		$90 Hold
3,450
– – ﹤0.01% 1796
2020
Q4 		$87K Buy
3,450
+220
+7% +$4.74K ﹤0.01% 1793
2020
Q3 		$67K Sell
3,230
-22,297
-87% -$506K ﹤0.01% 1684
2020
Q2 		$606K Buy
25,527
+23,360
+1,078% +$516K 0.01% 954
2020
Q1 		$39K Buy
2,167
+600
+38% +$12.6K ﹤0.01% 1578
2019
Q4 		$37K Sell
1,567
-8,203
-84% -$199K ﹤0.01% 1583
2019
Q3 		$268K Buy
9,770
+593
+6% +$17.6K ﹤0.01% 1256
2019
Q2 		$304K Hold
9,177
– – ﹤0.01% 1217
2019
Q1 		$322K Buy
9,177
+8,857
+2,768% +$330K ﹤0.01% 1182
2018
Q4 		$11K Hold
320
– – ﹤0.01% 1635
2018
Q3 		$16K Hold
320
– – ﹤0.01% 1592
2018
Q2 		$19K Hold
320
– – ﹤0.01% 1546
2018
Q1 		$15K Sell
320
-50
-14% -$2.09K ﹤0.01% 1538
2017
Q4 		$15K Hold
370
– – ﹤0.01% 1626
2017
Q3 		$15K Hold
370
– – ﹤0.01% 1616
2017
Q2 		$16K Hold
370
– – ﹤0.01% 1554
2017
Q1 		$12K Sell
370
-330
-47% -$8.84K ﹤0.01% 1617
2016
Q4 		$18K Buy
+700
New +$15.6K ﹤0.01% 1672

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Nisa Investment Advisors's SUPN Position: Q2 2026 in Review

Nisa Investment Advisors increased its Supernus Pharmaceuticals (SUPN) stake by 13% in Q2 2026, buying an estimated $10.4K and bringing the position to 1,873 shares worth $87.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1611.

Nisa Investment Advisors first reported a position in SUPN in Q4 2016 and has held it in 39 quarters since. The position peaked at $606K in Q2 2020. 138 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Nisa Investment Advisors held 1,873 shares of Supernus Pharmaceuticals worth $87.1K as of Q2 2026.
  • Nisa Investment Advisors bought 216 Supernus Pharmaceuticals shares in Q2 2026, an estimated $10.4K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1611 holding.
  • Nisa Investment Advisors first reported a position in Supernus Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
  • Nisa Investment Advisors's Supernus Pharmaceuticals position peaked at $606K in Q2 2020.
  • 138 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.